Contract development of enzyme preparations and GMP contract manufacturing.
Libra Medicina Co., Ltd. is the exclusive agent in Japan for Mycenax, a Taiwan-based CRO/CDMO specializing in biotechnology.
By ensuring consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized!
Our company is the exclusive agent in Japan providing contract manufacturing and GMP contract manufacturing (CRO/CMO) services for Mycenax Biotech Inc.'s biopharmaceuticals. Mycenax is capable of contract development and manufacturing for a variety of biopharmaceuticals, including antibody drugs. The target formulations include monoclonal antibodies, multi-specific antibodies, ADCs, enzymes, recombinant proteins, cell therapy products, and plasmid DNA. High-quality and efficient manufacturing is possible at our PIC/S GMP-compliant facility that adheres to international standards. With the implementation of a Quality Management System (QMS) and LIMS, we are fully prepared for audits. 【Features】 ■ Compliance with international regulations and proven track record with regulatory inspections ■ Smooth project progress with one-stop manufacturing for DS/DP ■ Equipped with dedicated facilities to support the production of diverse cell lines and high-potency formulations \ For more details, please check "Download Catalog" /
Inquire About This Product
basic information
For more details, please download the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the catalog or feel free to contact us.
catalog(2)
Download All CatalogsCompany information
Libra Medicina Co., Ltd. aims to contribute to the improvement of health and quality of life for people around the world by being involved in the creation of innovative pharmaceuticals and medical devices through development support services and licensing activities, delivering hope to patients suffering from serious diseases.